EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Twelve Weeks of Intermittent Caloric Restriction Diet Mitigates Neuroinflammation in Midlife Individuals with Multiple Sclerosis: A Pilot Study with Implications for Prevention of Alzheimer’s Disease

Farzaneh Rahmani, Laura Ghezzi, Valeria Tosti, Jingxia Liu, Sheng-Kwei Song, Anthony T Wu, Jayashree Rajamanickam, Kathleen A Obert, Tammie L S Benzinger, Bettina Mittendorfer, Laura Piccio, Cyrus A Raji

Journal of Alzheimer's Disease · 02.05.2023 · 93 (1) · 263-273

DOI: 10.3233/jad-221007 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Alzheimer's Disease, erschienen am 02.05.2023. Verfasst von Farzaneh Rahmani und 11 weiteren Autor:innen. Beteiligte Einrichtung: Mallinckrodt Institute of Radiology, Division of Neuroradiology, Washington University in St. Louis, St. Louis, MO, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Multiple Sclerosis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIA NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multiple sclerosis (MS) is a prototype neuroinflammatory disorder with increasingly recognized role for neurodegeneration. Most first-line treatments cannot prevent the progression of neurodegeneration and the resultant disability. Interventions can improve symptoms of MS and might provide insights into the underlying pathology.

Objective

To investigate the effect of intermittent caloric restriction on neuroimaging markers of MS.

Methods

We randomized ten participants with relapsing remitting MS to either a 12-week intermittent calorie restriction (iCR) diet (n = 5) or control (n = 5). Cortical thickness and volumes were measured through FreeSurfer, cortical perfusion was measured by arterial spin labeling and neuroinflammation through diffusion basis spectrum imaging.

Results

After 12 weeks of iCR, brain volume increased in the left superior and inferior parietal gyri (p: 0.050 and 0.049, respectively) and the banks of the superior temporal sulcus (p: 0.01). Similarly in the iCR group, cortical thickness improved in the bilateral medial orbitofrontal gyri (p: 0.04 and 0.05 in right and left, respectively), the left superior temporal gyrus (p: 0.03), and the frontal pole (p: 0.008) among others. Cerebral perfusion decreased in the bilateral fusiform gyri (p: 0.047 and 0.02 in right and left, respectively) and increased in the bilateral deep anterior white matter (p: 0.03 and 0.013 in right and left, respectively). Neuroinflammation, demonstrated through hindered and restricted water fractions (HF and RF), decreased in the left optic tract (HF p: 0.02), and the right extreme capsule (RF p: 0.007 and HF p: 0.003).

Conclusion

These pilot data suggest therapeutic effects of iCR in improving cortical volume and thickness and mitigating neuroinflammation in midlife adults with MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMultiple SclerosisHumansBrainCaloric RestrictionMagnetic Resonance ImagingNeuroinflammatory DiseasesPilot Projects

Stichwörter der Autor:innen

Alzheimer’s diseasearterial spin labelingcaloric restrictiondiffusion basis spectrum imagingmultiple sclerosisneuroinflammationpreventionrelative cerebral blood flow

Autor:innen und Institutionen

  • Mallinckrodt Institute of Radiology, Division of Neuroradiology, Washington University in St. Louis, St. Louis, MO, USA.
  • Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
  • Department of Surgery, Division of Public Health Sciences, Washington University in St. Louis, St. Louis, MO, USA.
  • Department of Physics, Washington University in St. Louis, St. Louis, MO, USA.
  • Hope Center for Neurological Disorders, Washington University in St. Louis, St. Louis, MO, USA.
  • Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St Louis, St. Louis, MO, USA.

Förderung

  • NIDDK NIH HHS
  • NIA NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Rahmani, F., Ghezzi, L., Tosti, V., Liu, J., Song, S. K., Wu, A. T., Rajamanickam, J., Obert, K. A., Benzinger, T. L. S., Mittendorfer, B., Piccio, L., & Raji, C. A. (2023). Twelve Weeks of Intermittent Caloric Restriction Diet Mitigates Neuroinflammation in Midlife Individuals with Multiple Sclerosis: A Pilot Study with Implications for Prevention of Alzheimer’s Disease. Journal of Alzheimer's Disease, 93(1), 263-273. https://doi.org/10.3233/jad-221007

Vancouver

Rahmani F, Ghezzi L, Tosti V, Liu J, Song SK, Wu AT, et al. Twelve Weeks of Intermittent Caloric Restriction Diet Mitigates Neuroinflammation in Midlife Individuals with Multiple Sclerosis: A Pilot Study with Implications for Prevention of Alzheimer’s Disease. Journal of Alzheimer's Disease. 2023;93(1):263-273. doi:10.3233/jad-221007

BibTeX
@article{Rahmani2023,
  author = {Rahmani, Farzaneh and Ghezzi, Laura and Tosti, Valeria and Liu, Jingxia and Song, Sheng-Kwei and Wu, Anthony T and Rajamanickam, Jayashree and Obert, Kathleen A and Benzinger, Tammie L S and Mittendorfer, Bettina and Piccio, Laura and Raji, Cyrus A},
  title = {Twelve Weeks of Intermittent Caloric Restriction Diet Mitigates Neuroinflammation in Midlife Individuals with Multiple Sclerosis: A Pilot Study with Implications for Prevention of Alzheimer’s Disease},
  journal = {Journal of Alzheimer's Disease},
  year = {2023},
  volume = {93},
  number = {1},
  pages = {263--273},
  doi = {10.3233/jad-221007}
}
Kostenlos starten →